![]() |
VERY WELL POSITIONED FOR THE FUTUREArevipharma offers three state-of-the-art, multi-purpose plants with a total reactor volume capacity of 150 m3, whichcomply with the cGMP standard and meet almost all customer requirements.
|
Pilot Plant for Manufacturing of Active Pharmaceutical Ingredients |
|
![]() The pilot plant is optimally suited to the efficient process development and production of small batch sizes up to 50 kgs. A flexible infrastructure enables us to perform highly complex syntheses even at this scale. |
Capacities
|
Multi-Purpose Plant |
|
![]() |
Capacities
|
Multi-Purpose Plant for highly active compounds |
|
![]() |
Capacities
|
Our Technologies |
|
![]() Our facilities and our special, longstanding expertise in the synthesis of complex organic compounds allow us to offer to our customers a broad range of synthetic processes and technologies applicable in almost all scales. |
|
GMP kilo lab and second piloting plantIn the year 2017 we will build up a GMP kilo lab and a second piloting plant, where highly potent drugs up to an occupational exposure level (OEL) of less than 1 µg/m³ will be handled safely. |